Cluevs
Flo


Flo: If you want to compare a competing app with a different ownership and regulatory history before choosing

Period and cycle tracking app owned by German company Biowink, positioned around science based tracking and a published stance against sharing data with law enforcement
As of 1 September 2026, Clue is free to use. A menstrual cycle tracking app built by Berlin-based Biowink, which markets itself specifically on scientific rigour and data protection under EU rules, and has publicly stated it will not share reproductive health data with law enforcement without a valid legal process and will resist requests it believes are improper. Softwr lists it under Healthcare. Clue is made by Biowink GmbH, available on iOS, Android.
Overview
Clue tracks periods, ovulation, symptoms and mood, generating cycle predictions and pattern insights from logged data, with the company positioning the app around scientific advisory input and research partnerships rather than lifestyle content as its main differentiator from competitors like Flo. Data handling is the central fact for this category and Clue has made it central to its own marketing, which still needs to be checked against the actual published policy rather than taken at face value. Clue is a German company operating under EU data protection law (GDPR), and it publishes a privacy policy stating it does not sell personal data to advertisers and does not share health data with law enforcement or public authorities without a legally binding request, adding that it would challenge requests it considers improper; the company has also stated its EU legal base makes it harder for US authorities to compel disclosure than for a US-based competitor. These are the vendors published claims and stated legal position, not an independent guarantee, and a user with specific legal concerns in a hostile jurisdiction should verify current policy language directly rather than rely on marketing summaries, including this one. Buyers are people who want cycle tracking and are specifically weighing data jurisdiction and legal exposure alongside app quality, given the same reproductive health data sensitivity that applies to Flo. The trade-off against Flo is stated positioning: Clue markets itself heavily on the strength of EU-based data protection and a public no-law-enforcement-sharing stance, while Flo operates under a settlement history that a buyer should weigh in the other direction; comparing the two on their current published privacy policies, not just brand reputation, is the right way to decide.
The honest half
Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Clue.
Cross-shopped
Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.


Flo: If you want to compare a competing app with a different ownership and regulatory history before choosing


Peanut: If you want a community focused app for fertility, pregnancy and early parenting rather than cycle tracking specifically
Pricing
Taken from the vendor's own pricing page. Prices move, so check before you buy.
Clue Plus
$9.99 /mo
Capabilities
Cycle and symptom tracking
Logged period, ovulation, symptom and mood data used to generate predictions
Cycle insights and patterns
Pattern recognition across logged cycles, deeper insights on Clue Plus
Research partnerships
Clue has run academic research studies using opt-in anonymised user data
EU-based data hosting
Company states data is handled under EU GDPR rules as a German entity
Fertility and conception mode
Ovulation and fertile window tracking for users trying to conceive
Perimenopause and other life stage tracking
Tracking modes beyond the standard reproductive years cycle
Answered, with sources
Each answer names the page it came from, so you can check it rather than take our word for it.
Clue publishes a policy stating it does not share health data with law enforcement or public authorities without a legally binding request and states it will challenge requests it considers improper. This is the companys stated position; verify the current policy directly for specifics.
Clue operates under EU GDPR data protection rules and states this legal basis makes it harder for authorities outside the EU, including US authorities, to compel data disclosure than for a company based in the US.
Core cycle tracking, logging and basic predictions are free. Deeper insights and extended predictions require Clue Plus.
Keep looking
Period and cycle tracking app that settled with the US FTC in 2021 over sharing health data with third parties despite promising not to
Pharmacy management system built for independent community pharmacies
Generative reporting and follow-up tracking for radiology, positioned outside the diagnostic device boundary
French mammography AI with FDA clearances for 2D and tomosynthesis breast screening
Employer purchased mental health benefit with a curated provider network and measurement based care
Employer and health plan digital mental health, acquired by PsychPlus in June 2026
Open source electronic medical record platform for low-resource settings, with no vendor and paid implementers instead
Server-side streaming PACS built for radiologists reading very large studies over thin connections
CE marked and FDA cleared imaging AI suite for bone trauma and chest, now owned by RadNet
Healthcare navigation for self insured employers, delivered by pods of human care coordinators
AI digital pathology across clinical, veterinary and environmental laboratory disciplines
On-premise EHR solution for physician practices and hospitals
French mammography AI with FDA clearances for 2D and tomosynthesis breast screening
Softwr does not host reviews and shows no star rating for Clue, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.
What people switch to, and what they give up
Every tier, and where the cost actually lands
Put it head to head with anything we hold
Its rating, and an embed for your own site
Clinical laboratory middleware and informatics from a diagnostics instrument manufacturer
quoteOpen source hospital information system and EMR for low-resource hospitals, built on OpenMRS
Open source, no licence feePeriod and cycle tracking app that settled with the US FTC in 2021 over sharing health data with third parties despite promising not to
Free with a Premium subscriptionOpen source health information platform run from the University of Oslo and used by national ministries
Open source, no licence feeMulti-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
quote